MedPath

Effects of Menstrual Cycle Phases on Gait, Pelvis, and Sleep

Recruiting
Conditions
Menstrual Cycle
Sleep
Gait
Registration Number
NCT07152262
Lead Sponsor
Hacettepe University
Brief Summary

This study aims to investigate the effects of different phases of the menstrual cycle on gait spatiotemporal characteristics, pelvic kinematics, and sleep quality in healthy women aged 18-35 years with regular menstrual cycles. Participants will be assessed in three phases of the cycle: early follicular (days 1-3), ovulation (days 7-9, confirmed by ovulation test), and luteal (days 20-23). Gait parameters and pelvic kinematics will be evaluated using the BTS-G walk sensor system, while sleep quality will be assessed with the Pittsburgh Sleep Quality Index (PSQI). The study seeks to determine whether physiological and hormonal changes during menstrual phases lead to measurable differences in gait, pelvic motion, and sleep quality.

Detailed Description

This cross-sectional, prospective observational study investigates the influence of menstrual cycle phases on gait spatiotemporal characteristics, pelvic kinematics, and sleep quality in healthy women aged 18-35 years with regular menstrual cycles (28 ± 7 days). Hormonal changes during the cycle may affect musculoskeletal performance, balance, and sleep quality, yet the extent of these effects on gait and pelvic motion has not been fully clarified.

Participants will be evaluated in three phases of their menstrual cycle:

Early follicular phase (days 1-3), determined by the onset of menstrual bleeding, Ovulation phase (days 7-9), confirmed by a salivary ovulation test, Luteal phase (days 20-23), approximately 6-8 days after ovulation. At each phase, gait spatiotemporal parameters (speed, cadence, stride length, stance and swing phases, gait cycle duration) and pelvic kinematics (tilt, obliquity, rotation symmetry) will be assessed using the BTS-G walk wireless sensor system. Sleep quality will be measured with the Pittsburgh Sleep Quality Index (PSQI).

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • Female, aged 18-35 years
  • Voluntarily agrees to participate and provides informed consent
  • Regular menstrual cycle (28 ± 7 days)
  • Able to comply with study assessments and procedures
Exclusion Criteria
  • History of surgery within the past 6 months
  • Current or chronic low back pain
  • Dysmenorrhea complaints
  • Neurological or orthopedic disorders affecting gait or muscle strength
  • Presence of spinal deformities
  • Rheumatologic disease
  • Climacteric or menopausal period
  • Any condition that may affect gait, pelvic kinematics, or sleep quality

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in Gait Speed Across Menstrual PhasesWithin one menstrual cycle (~3-4 weeks).

Within-subject change in comfortable gait speed (meters/second (m/s)) measured by BTS-G walk sensor in three phases: early follicular (days 1-3), ovulation (days 7-9; salivary test-confirmed), luteal (days 20-23).

Change in Cadence Across Menstrual PhasesWithin one menstrual cycle (~3-4 weeks).

Within-subject change in step cadence( steps/min) recorded by BTS-G walk across the same three phases.

Change in Pelvic KinematicsWithin one menstrual cycle (~3-4 weeks).

Within-subject change in pelvic tilt (degree), obliquity (degree), and rotation symmetry (degree) indices obtained from BTS-G walk across phases.

Change in Stride Length Across Menstrual PhasesWithin one menstrual cycle (~3-4 weeks).

Within-subject change in stride length (centimeters/cm) captured by BTS-G walk across the three phases.

Change in Stance and Swing Phase PercentagesWithin one menstrual cycle (~3-4 weeks).

Within-subject change in stance (%) and swing (%) durations during gait across phases using BTS-G walk.

Change in Sleep QualityWithin one menstrual cycle (~3-4 weeks).

Within-subject change in Pittsburgh Sleep Quality Index (PSQI) global score across phases. The PSQI is scored between 0 and 21. Higher scores indicate poorer sleep quality.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Yuksek Ihtisas University

Ankara, Turkey (Türkiye)

Yuksek Ihtisas University
Ankara, Turkey (Türkiye)
Gungor Beyza Ozvar Senoz
Contact
beyzaozvar@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.